Soluble E-cadherin as a serum biomarker candidate: Elevated levels in patients with late-stage colorectal carcinoma and FAP

International Journal of Cancer

Volumn 128, Issue 6, 2011, Pages 1384-1392

  Weiß, Jakob V ^a   Klein Scory, Susanne ^a   Kübler, Salwa ^a   Reinacher Schick, Anke ^a   Stricker, Ingo ^b   Schmiegel, Wolff ^a,b   Schwarte Waldhoff, Irmgard ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

biomarker; colorectal cancer; secretome; shedding; soluble E cadherin

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; COLON RESECTION; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENTERITIS; FAMILIAL COLON POLYPOSIS; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; CHILD; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79551505279     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25438     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 2: 71-96.
2. Kievit J,. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002; 7: 986-99.
3. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG,. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 1: 24-8.
4. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E,. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006; 2: 343-50.
5. Bertz J, Giersiepen K, Haberland J, Hentschel S, Kaatsch P, Katalinic A, Stabenow R, Stegmaier C, Ziegler H,. Krebs in Deutschland, 5, überarb., aktualisierte Ausg. Saarbrücken: Gesellschaft der epidemiologischen Krebsregister in Deutschland, 2006.
6. Mansmann U, Crispin A, Henschel V, Adrion C, Augustin V, Birkner B, Munte A,. Epidemiology and quality control of 245 000 outpatient colonoscopies. Dtsch Arztebl Int 2008; 24: 434-40.
7. Allison JE, Tekawa IS, Ransom LJ, Adrain AL,. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 3: 155-9.
8. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD,. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA 1993; 10: 1262-7.
9. Gold P, Freedman SO,. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 3: 467-81.
10. Bivins BA, Meeker WR, Griffen WO, Pellegrini J, Parker JC,. Carcinoembryonic antigen (CEA) levels and tumor histology in colon cancer. J Surg Res 1975; 3: 257-61.
11. Duffy MJ,. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 4: 624-30.
12. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC, ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 33: 5313-27.
13. Volmer MW, Stühler K, Zapatka M, Schöneck A, Klein-Scory S, Schmiegel W, Meyer HE, Schwarte-Waldhoff I,. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics 2005; 10: 2587-601.
14. Diehl HC, Stühler K, Klein-Scory S, Volmer MW, Schöneck A, Bieling C, Schmiegel W, Meyer HE, Schwarte-Waldhoff I,. A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery. Proteomics Clin Appl 2007; 1: 47-61.
15. Damsky CH, Richa J, Solter D, Knudsen K, Buck CA,. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell 1983; 2: 455-66.
16. de Wever O, Derycke L, an Hendrix, de Meerleer G, Godeau F, Depypere H, Bracke M,. Soluble cadherins as cancer biomarkers. Clin Exp Metastasis 2007; 8: 685-97.
17. Najy AJ, Day KC, Day ML,. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J Biol Chem 2008; 26: 18393-401.
18. Wilmanns C, Grossmann J, Steinhauer S, Manthey G, Weinhold B, Schmitt-Graff A, von Specht BU,. Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients. Clin Exp Metastasis 2004; 1: 75-8.
19. Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, Hall NR, Jones M, Wyatt J, Miller K, Ward U, Al-Maskatti J, et al. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 1998; 11: 1857-63.
20. Richter M, Jurek D, Wrba F, Kaserer K, Wurzer G, Karner-Hanusch J, Marian B,. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur J Cancer 2002; 14: 1937-45.
21. Baldus SE, Zirbes TK, Engel S, Hanisch FG, Mönig SP, Lorenzen J, Glossmann J, Fromm S, Thiele J, Pichlmaier H, Dienes HP,. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer 1998; 2: 133-8.
22. Pittard AJ, Banks RE, Galley HF, Webster NR,. Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth 1996; 5: 629-31.
23. Graham RA, Wang S, Catalano PJ, Haller DG,. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest X-ray, and colonoscopy. Ann Surg 1998; 1: 59-63.
24. Renehan AG, Egger M, Saunders MP, O'Dwyer ST,. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 7341: 813.
25. Tsanou E, Peschos D, Batistatou A, Charalabopoulos A, Charalabopoulos K The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 2008; 6: 3815-26.
26. van Roy F, Berx G,. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 23: 3756-88.
27. Reiss K, Ludwig A, Saftig P,. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther 2006; 3: 985-1006.
28. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O,. Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 2001; 7: 4972-80.
29. Berkhout M, Gosens MJEM, Brouwer KM, Peters WHM, Nagengast FM, van Krieken JHJM, Nagtegaal ID,. Loss of extracellular E-cadherin in the normal mucosa of duodenum and colon of patients with familial adenomatous polyposis. Hum Pathol 2006; 11: 1389-99.
30. Yap AS, Crampton MS, Hardin J,. Making and breaking contacts: the cellular biology of cadherin regulation. Curr Opin Cell Biol 2007; 5: 508-14.
31. D'Souza-Schorey C,. Disassembling adherens junctions: breaking up is hard to do. Trends Cell Biol 2005; 1: 19-26.
32. Keller S, Sanderson MP, Stoeck A, Altevogt P,. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006; 2: 102-8.
33. Mosesson Y, Mills GB, Yarden Y,. Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 2008; 11: 835-50.